kt-413
Showing 1 - 1 of 1
Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, DLBCL Trial in United States (KT-413)
Recruiting
- Non Hodgkin Lymphoma
- +3 more
- KT-413
-
Washington, District of Columbia
- +5 more
Nov 29, 2022